AbbVie
ABBV
#30
Rank
C$435.87 B
Marketcap
$246.66
Share price
0.10%
Change (1 day)
19.52%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of September 2024 : C$8.63 Billion

According to AbbVie's latest financial reports the company has C$8.63 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$C$13.79 B-41.21%
2022-12-31$C$23.45 B19.24%
2021-12-31$C$19.67 B17.8%
2020-12-31$C$16.69 B-256.46%
2019-12-31$-C$10.68 Billion-7.23%
2018-12-31$-C$11.51 Billion-279.54%
2017-12-31$C$6.40 B2.86%
2016-12-31$C$6.23 B13.84%
2015-12-31$C$5.47 B170.71%
2014-12-31$C$2.02 B-57.72%
2013-12-31$C$4.78 B42.99%
2012-12-31$C$3.34 B-72.45%
2011-12-31$C$12.13 B-22.68%
2010-12-31$C$15.69 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$131.68 B 1,424.59%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.47 B 183.31%๐Ÿ‡บ๐Ÿ‡ธ USA
C$20.37 B 135.89%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.70 B 23.98%๐Ÿ‡บ๐Ÿ‡ธ USA
C$26.16 B 202.92%๐Ÿ‡บ๐Ÿ‡ธ USA
C$23.27 B 169.46%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.61 B 196.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$58.05 B 572.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$3.86 B-55.21%๐Ÿ‡บ๐Ÿ‡ธ USA